Does CISPLATIN Cause Tumour marker increased? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Tumour marker increased have been filed in association with CISPLATIN (CISplatin). This represents 0.0% of all adverse event reports for CISPLATIN.
15
Reports of Tumour marker increased with CISPLATIN
0.0%
of all CISPLATIN reports
1
Deaths
2
Hospitalizations
How Dangerous Is Tumour marker increased From CISPLATIN?
Of the 15 reports, 1 (6.7%) resulted in death, 2 (13.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does CISPLATIN Cause?
Off label use (4,359)
Disease progression (3,746)
Neutropenia (3,095)
Febrile neutropenia (3,010)
Nausea (2,923)
Drug ineffective (2,608)
Thrombocytopenia (2,565)
Anaemia (2,530)
Vomiting (2,326)
Diarrhoea (2,022)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which CISPLATIN Alternatives Have Lower Tumour marker increased Risk?
CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE
CISPLATIN vs CITALOPRAM
CISPLATIN vs CITALOPRAM HYDROBROMIDE
CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE
CISPLATIN vs CITICOLINE